End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,370 KRW | +0.35% | +7.16% | -15.27% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -99% by 2026.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.27% | 282M | - | ||
-41.90% | 2.95B | C+ | ||
+19.36% | 1.88B | - | ||
-1.05% | 1.63B | - | ||
+33.96% | 1.34B | B+ | ||
-16.83% | 959M | - | ||
-21.96% | 888M | - | C- | |
+7.07% | 842M | - | ||
-26.98% | 623M | B+ | ||
+10.85% | 513M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A206640 Stock
- Ratings Boditech Med Inc.